Dose response of pancreatic neuroendocrine tumours treated with peptide receptor radionuclide therapy using 177Lu-DOTATATE

被引：0
|
作者：
Ilan, E. [1 ,2 ,3 ]
Sandstrom, M. [1 ,2 ,3 ]
Garske-Roman, U. [2 ,3 ]
Sundin, A. [2 ,3 ]
Wassberg, C. [2 ,3 ]
Lubberink, M. [1 ,2 ,3 ]
机构：
[1] Sect Med Phys, Uppsala, Sweden
[2] Nucl Med Sect, Uppsala, Sweden
[3] PET, Uppsala, Sweden
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2014年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP287
引用
收藏
页码：S223 / S224
页数：2
相关论文
共 50 条
  • [31] The efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in patients with metastatic neuroendocrine tumours: a systematic review and meta-analysis
    Zhang, Jie
    Song, Qi
    Cai, Liang
    Xie, Ying
    Chen, Yue
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (06) : 1533 - 1543
  • [32] The efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in patients with metastatic neuroendocrine tumours: a systematic review and meta-analysis
    Jie Zhang
    Qi Song
    Liang Cai
    Ying Xie
    Yue Chen
    [J]. Journal of Cancer Research and Clinical Oncology, 2020, 146 : 1533 - 1543
  • [33] Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATE
    Zandee, Wouter T.
    Feelders, Richard A.
    Duijzentkunstz, Daan A. Smit
    Hofland, Johannes
    Metselaar, R. Mick
    Oldenburg, Rogier A.
    van Linge, Anne
    Kam, Boen L. R.
    Teunissen, Jaap J. M.
    Korpershoek, Esther
    Hendriks, Johanna M.
    Abusaris, Huda
    Slagter, Cleo
    Franssen, Gaston J. H.
    Brabander, Tessa
    De Herder, Wouter W.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2019, 181 (01) : 45 - 53
  • [34] Comparison of commercial dosimetric software platforms in patients treated with 177Lu-DOTATATE for peptide receptor radionuclide therapy
    Mora-Ramirez, Erick
    Santoro, Lore
    Cassol, Emmanuelle
    Ocampo-Ramos, Juan C.
    Clayton, Naomi
    Kayal, Gunjan
    Chouaf, Soufiane
    Trauchessec, Dorian
    Pouget, Jean-Pierre
    Kotzki, Pierre-Olivier
    Deshayes, Emmanuel
    Bardies, Manuel
    [J]. MEDICAL PHYSICS, 2020, 47 (09) : 4602 - 4615
  • [35] Peptide Receptor Radionuclide Therapy (PRRT) Using 177Lu-DOTATATE: Early Clinical and Dosimetric Results
    Garkavij, M.
    Nickel, M.
    Sjogreen-Gleisner, K.
    Ljungberg, M.
    Strand, S. E.
    Ohlsson, T.
    Tennvall, J.
    [J]. NEUROENDOCRINOLOGY, 2009, 90 (01) : 113 - 113
  • [36] Peptide receptor radionuclide therapy (PRRT) using 177Lu-Dotatate:: Early clinical and dosimetric results
    Garkavij, M.
    Sjogreen-Gleisner, K.
    Nickel, M.
    Ohlsson, T.
    Wingardh, K.
    Tennvall, J.
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2008, 23 (04) : 524 - 525
  • [37] Neuroendocrine Tumor Therapy: 177Lu-DOTATATE
    Mittra, Erik S.
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2018, 211 (02) : 278 - 285
  • [38] Management of a Patient With Metastatic Gastrointestinal Neuroendocrine Tumor and Meningioma Submitted to Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE
    Pirisino, Riccardo
    Filippi, Luca
    D'Agostini, Antonio
    Bagni, Oreste
    [J]. CLINICAL NUCLEAR MEDICINE, 2022, 47 (11) : E692 - E695
  • [39] Data collection procedures for bone marrow dosimetry in peptide receptor radionuclide therapy with 177Lu-DOTATATE on neuroendocrine tumors
    Frederiksen, M. H. B.
    Klausen, T. L.
    de Nijs, R.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S631 - S631
  • [40] 177Lu-DOTATATE peptide receptor radionuclide therapy versus Everolimus in advanced pancreatic neuroendocrine tumors: a systematic review and meta-analysis
    Satapathy, Swayamjeet
    Mittal, Bhagwant Rai
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (12) : 1195 - 1203
12345